The Drug Controller General of India (DCGI) has asked drug regulators in all states and Union territories to withdraw AstraZeneca s anti-cancer drug Olaparib tablets for treatment in patients who have received three or more prior lines of chemotherapy.
Fighting rare diseases through innovation - The Hindu BusinessLine thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.
Water consumption in large listed companies registered in Bengaluru rose in fiscal year 2022-23, but some also showed commitment to reduce their water footprint and recycle more.
AstraZeneca Pharma India appoints Vinay Sharma as business unit head thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.
AstraZeneca Pharma India Ltd and Mankind Pharma Ltd on Monday said they have entered into an agreement for exclusive distribution of the Symbicort brand, an asthma medicine, in India.
Symbicort is owned by AstraZeneca, which will retain the intellectual property rights and will continue to be the